Irritable bowel syndrome in Mexico

Digestive Diseases

Volumn 19, Issue 3, 2001, Pages 251-257

  Huerta, Ivonne ^a   Valdovinos, Miguel Angel ^a   Schmulson, Max ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Epidemiology; Irritable bowel syndrome; Quality of life; Rome criteria

Indexed keywords

LIDAMIDINE; PINAVERIUM BROMIDE; SPASMOLYTIC AGENT;

ABDOMINAL PAIN; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; GASTROINTESTINAL SYMPTOM; HEALTH CARE UTILIZATION; HUMAN; IRRITABLE COLON; MALE; MEXICO; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PSYCHOTHERAPY; QUALITY OF LIFE; SEX DIFFERENCE; SOCIAL PSYCHOLOGY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CLINICAL TRIALS; COLONIC DISEASES, FUNCTIONAL; FEMALE; HEALTH SERVICES; HUMANS; MALE; MEXICO; MIDDLE AGED; PREVALENCE; PROGNOSIS; QUALITY OF LIFE; SEX FACTORS; TREATMENT OUTCOME;

EID: 0035671372     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000050688     Document Type: Article

References (60)

1. Irritable bowel syndrome: A technical review for practice guideline development
2. Management of the irritable bowel syndrome
3. Brain-gut interactions: Implications for newer therapy
4. Brain-gut interaction in irritable bowel syndrome: New findings of a multicomponent disease model
5. Nuevas orientaciones en trastornos funcionales del aparato digestivo
6. Trastornos funcionales gastroduodenales
7. Current concepts in the management of the irritable bowel syndrome
8. Enfermedad digestiva y padecer digestivo
9. Síndrome de intestino irritable: ¿Trastorno inflamatorio, Motor, sensitivo o psicológico?
10. Tratornos funcionales digestivos, estudio doble ciego con doxepin
11. Correlación fisio-radiologica rectoanal en pacientes con síndrome de intestino irritable
12. Consumo excesivo de alcohol en la población rural: Aplicacion del cuestionario AUDIT y su correlación con factores socioeconómicos y síntomas de intestino irritable
13. Correlación del dolor y la distension abdominal con la motilidad rectoanal en el síndrome de intestino irritable
14. Food influence rectal sensitivity in constipation predominant irritable bowel syndrome latin patients
15. Estudio aleatorio doble ciego controlado con placebo con aceite de menta piperita, respuesta electromecánica rectoanal a la comida en el síndrome de intestino irritable
16. Tratamiento de colon irritable con lidamidina y psicoterapia de apoyo
17. Transrectal ultrasonography: Relationship with anorectal manometry, electromyography and sensitivity tests in irritable bowel syndrome
18. A randomised double-blind placebo-controlled trial of lidamidine HCl in irritable bowel syndrome
19. Do anorectal parameters of ultrasonography, defecography, manometry, and electromyography correlate in irritable bowel syndrome?
20. Colon irritable
21. Irritable bowel syndrome treatment using pinaverium bromide as a calcium channel blocker. A randomized double-blind placebo-controlled trial
22. Defaecography in patients with irritable bowel syndrome and healthy volunteers
23. Reduction of post-prandial motility by pinaverium bromide a calcium channel blocker acting selectively on the gastrointestinal tract in patients with irritable bowel syndrome
24. Utilización de recursos médicos por los pacientes con síndrome de intestino irritable en un hospital de tercer nivel
25. Aspectos epidemiológicos de los trastornos funcionales digestivos
26. Epidemiología de los trastornos disfuncionales del tubo digestivo (intestino irritable) resultado de una encuesta aplicada en población rural abierta
27. Prevalencia de los trastornos funcionales digestivos en estudiantes de medicina
28. A physiological response of rectal hypersensitivity is triggered after meals in female constipation predominant irritable bowel syndrome patients
29. Los pacientes con trastornos funcionales digestivos (TFD) tienen mayor compromiso de la calidad de vida (CV) evaluada por el SF-36 comparados con pacientes con hepatitis C y pancreatitis cónica
30. Concordancia entre los criterios de Roma I y Roma II para el diagnó stico del síndrome de colon iritable (SCI)
31. Trastornos del afecto. ¿Factor de riesgo para padecer trastornos funcionales digestivos?
32. Dolor abdominal crónico (DAC) en niños: ¿Síndrome de intestino irritable (SII) vs. dispepsia no ulcerosa (DNU)?
33. El chile en la dieta disminuye el umbral sensorial rectal evaluado por barostato en pacientes con síndrome de colon irritable (SCI)
34. Asociación Mexicana de Gastroenterología: Simposio: Trastornos funcionales del tubo digestivo (Resultado de la Encuesta Nacional)
35. Functional bowel disorders and functional abdominal pain
36. US householder survey of functional gastrointestinal disorders: Prevalence, sociodemography and health impact
37. Irritable bowel-type symptoms in HMO examinees. Prevalence, demographics and clinical correlates
38. Psychosocial factors in the irritable bowel syndrome
39. Role of psychological symptoms in irritable bowel syndrome: Comparison of community and clinical samples
40. Evidence that abnormal myoelectrical activity produces colonic motor dysfunction in the bowel syndrome
41. Diagnostic approach to the patients with irritable bowel syndrome
42. Irritable bowel syndrome: Guidelines for the diagnosis
43. Functional bowel disorders and functional abdominal pain
44. Functional bowel disorders and functional abdominal pain
45. Symptom differences in moderate to severe IBS patients on predominant bowel habit
46. Irritable bowel syndrome in a community: Symptom subgroups, risk factors, and health care utilization
47. Pain from distension of the pelvic colon by inflating a balloon in the irritable bowel syndrome
48. Anorectal manometry in irritable syndrome: Differences between diarrhoea and constipation predominant subjects
49. Altered rectal perception is a biological marker of patients with irritable bowel syndrome
50. Sigmoid afferent mechanisms in patients with irritable bowel syndrome
51. Correlation of symptom criteria with perception thresholds during rectosigmoid distension in irritable bowel syndrome patients
52. Discrepancies between reported food intolerance and sensitization test findings in irritable bowel syndrome patients
53. Functional bowel disorders and the visceral hyperalgesia hypothesis
54. Physiology of refractory chronic constipation
55. Pharmacologic treatment of the irritable bowel syndrome: A systematic review of randomized, controlled trials
56. Adrenergic modulation of human colonic motor and sensory function
57. Quality of life measurement in gas-troenterology: What is available
58. Quality of life assessment by patients with inflammatory bowel disease
59. The impact of irritable bowel syndrome on health related quality of life
60. Evaluación del estado de salud con la Encuesta SF-36: Resultados preliminares en México